03/05/2020

Aux États-Unis, 60 % des études cliniques sur le cancer interrompues par l’épidémie de Covid-19

Les patients atteints de cancer constituent une population particulièrement vulnérable au risque de formes graves d'infection par le SARS-CoV-2, le HCSP ayant à ce titre publié des recommandations spécifiques. Aussi les oncologues sont-ils extrêmement préoccupés par le risque d'infection de leurs patients.

Source: www.lequotidiendumedecin.fr

04/05/2020

IBM launches blockchain network to bolster medical supply chain during COVID-19 #esante #hcsmeufr #digitalhealth #Coronavirus #covid-19 #COVID19FR #coronavirusfrance

Rapid Supplier Connect is designed to help health systems and government agencies identify and onboard alternative vendors when certain supplies and PPE are in shortage.

Source: www.healthcareitnews.com

04/05/2020

FDA authorizes NASA-designed ventilator for COVID-19 #esante #hcsmeufr #digitalhealth #Coronavirus #covid-19 #COVID19FR #coronavirusfrance

While NASA took enterprising steps last week toward returning astronauts to the moon by 2024, it also moved forward with a more terrestrial endeavor by receiving an FDA emergency authorization for a ventilator designed for the COVID-19 pandemic.

Dubbed VITAL, for Ventilator Intervention Technology Accessible Locally, the high-pressure device was developed by engineers at the Jet Propulsion Laboratory (JPL) in California and was described by NASA Administrator Jim Bridenstine as an concrete example of the agency’s space-based skills and research being applied on Earth.

VITAL is designed to be built faster and easier than a traditional ventilator, and with fewer parts. However, it is not made to last as long as typical hospital hardware—just three or four months compared to years for a more durable device.

"Now that we have a design, we're working to pass the baton to the medical community, and ultimately patients, as quickly as possible," said Fred Farina, chief innovation and corporate partnerships officer at Caltech, which is freely providing JPL’s product license and searching for commercial manufacturers.

The FDA’s green light allows the device to be used specifically for COVID-19 patients. In addition, it is constructed with components from outside the medical device supply chain, according to the agency, to lessen the impact on the supplies needed for currently made ventilators.

Source: www.fiercebiotech.com

04/05/2020

Predictive Analytics Models Help Plan for COVID-19 Demands #esante #hcsmeufr #digitalhealth #Coronavirus #covid-19 #COVID19FR #coronavirusfrance

To inform decision-making during the COVID-19 pandemic, Cleveland Clinic has created predictive analytics models that help forecast patient volume, bed capacity, ventilator availability, and other metrics.

With COVID-19 rapidly spreading among patient populations, hospitals and health systems are facing unprecedented strains on resources and capacity. Organizations are increasingly turning to real-time analytics tools to help track and predict healthcare demands.

The predictive models, developed by Cleveland Clinic and SAS, provide timely, reliable information for hospitals and health systems to optimize care delivery for COVID-19 and other patients.

The analytics models were designed to create worst-case, best-case, and most-likely scenarios, unlike some forecasts that focus on a prediction based on a single set of assumptions. The models can adjust in real time as situations and data change, such as social distancing measures and disease spread.

Using this information, Cleveland Clinic can predict and plan for future demands on the health system, including ICU beds, personal protective equipment, and ventilators. After reviewing possible COVID-19 surge scenarios generated by the models, Cleveland Clinic activated a plan to prepare for its worst-case scenario. The health system built a 1,000-bed surge hospital on its education campus for COVID-19 patients who don’t need ICU care.

Source: healthitanalytics.com

Aller au contenu principal